Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Waldenstrom Macroglobulinemia 3Rectal Neoplasms 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Intraocular Lymphoma 2Hodgkin Disease 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms, Male 2Unspecified Childhood Solid Tumor, Protocol Specific 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Enzyme-Linked Immunosorbent Assay × Clear all
NCT00425672 2018-12-05

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

University of Washington

Phase 1/2 Completed
15 enrolled 13 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01385280 2018-10-17

Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

University of Arizona

Phase NA Completed
13 enrolled 6 charts
Breast

Breast Neoplasms

NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01105312 2017-06-27

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 1/2 Completed
28 enrolled 13 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡